Dr Ankush Raut Fertility Consultant

04/12/2025

https://youtu.be/pUnYX_4pE7w?si=v7Ve-HU35vvRlCAI

I have mentioned my complete cost details on the IVF treatment

04/12/2025

https://youtube.com/shorts/EMaMfxBYpYw?si=9qUv0FL-aMxNWxEV

Timing is key! Learn when to seek expert advice from a fertility consultant with Dr. Ankush Raut. Ready to start your journey? Contact us today! ...

04/12/2025

https://youtube.com/shorts/yC2ngYJFy3Y?si=6xDx-RzAvUK8ArB_

Struggling with infertility? In this Fertility Talk, Dr. Ankush Raut shares expert insights to guide you on your path to parenthood💛 ...

04/12/2025

https://youtube.com/shorts/1KIk02Ep5UY?si=dvBWz0ERPVqdJ-4f

A blastocyst may be tiny, but it’s a big step toward your dream of parenthood. Learn more about blastocysts in this Fertility Talks by Dr. Ankush Raut. ...

03/12/2025

🌸 A Note to My Dear OBGY Colleagues: Why We Should Avoid Fancy Digital Fetosense-Type Machines

In recent years, several “smart” digital NST devices have entered the market claiming convenience, automation, and cloud-based advantages. But the reality in day-to-day clinical practice is very different — and often frustrating.

❌ 1. Hidden Costs & Forced Subscriptions
These companies frequently charge recurring fees for basic functions like:
• Patient name updation
• Report generation
• Cloud storage
• Software renewal
A one-time purchase becomes a never-ending money drain.

❌ 2. Over-Dependence on Apps & Internet
Digital devices rely heavily on:
• Mobile apps
• Wi-Fi
• Company servers
Any downtime means your patient flow suffers. An NST should never depend on network stability.

❌ 3. No Real Advantage Over Classic Machines
The “digital” features rarely add true clinical value.
Interpretation is still your expertise, not the app’s.
The output is the same – a fetal heart tracing you must read.

❌ 4. Service Issues & Lock-Ins
Companies often lock the device, refusing updates or service unless you pay.
If the company shuts down or changes policy, the machine becomes useless.

⸻

✔️ Why the Classic Offline NST Machine Still Wins

• One-time investment – no hidden or recurring charges.
• Rugged, reliable, and works anywhere – no apps, no internet.
• Full clinical control in your hands.
• Easy to service, easy to maintain, lasts 8–10 years.
• Perfect for busy OPDs, labour rooms, and peripheral setups.

⸻

💬 Final Message

Sometimes, simplicity beats “smartness.”
For something as essential as NST, a classic offline machine provides more reliability, more control, and better long-term value than any fancy digital gadget tied to renewals and subscriptions.

Choose practicality. Choose reliability. Choose an offline NST machine.

27/11/2025

Thousands of people in Sweden are actively replacing traditional keys, ID cards, and even bus passes with tiny "microchip implants" inserted just beneath their skin. This groundbreaking voluntary movement, which began around 2015, has rapidly grown into a mainstream trend across the country.

These rice-sized RFID or NFC chips function as digital keys, storing personal data and communicating seamlessly with external devices. With just a simple wave of the hand, users can unlock doors, board public transportation, or instantly share contact information, turning the human body into a highly convenient interface.

This shift represents a striking step toward human-digital integration. While these implants raise important questions about data privacy and security, they powerfully highlight how quickly humans are willing to adapt to futuristic technology when the benefits—chiefly, immense "convenience"—are immediate and tangible.

27/11/2025

Scientists have captured the moment fertilization occurs, and it's marked by a tiny flash of light they call the "zinc spark." This brief shimmer is caused by the egg rapidly releasing millions of zinc ions immediately upon successful contact with a s***m.

The glow is fleeting and only visible under powerful microscopes. First observed in mouse eggs, this phenomenon was later confirmed in human eggs as well. The presence of the zinc spark is now recognized as a reliable indicator that fertilization has succeeded.

This discovery provides a rare and stunning glimpse into the very beginning of life. It’s a remarkable visual testament, captured in a microscopic burst of light, signifying the exact instant that conception takes place.

18/11/2025

✨ Hysteroscopy plays a powerful role in boosting IVF success.
Sometimes tiny issues inside the uterus quietly affect implantation.
A simple, gentle evaluation helps create a clear and welcoming environment for the embryo.
It’s one of the most effective steps to improve IVF outcomes with confidence.
– Dr. Ankush Raut, Fertility Specialist

11/11/2025

21/10/2025

⚠️ Cancer Concerns Around Popular Weight-Loss Drugs Like Ozempic

Breakthrough medications like Ozempic, Wegovy, and Mounjaro—all GLP-1 receptor agonists—have transformed weight loss and diabetes management by lowering blood sugar and suppressing appetite. Yet as their use skyrockets, scientists are investigating possible long-term cancer risks associated with these drugs.

The strongest concern centers on thyroid cancer. Animal studies show that high doses of GLP-1 drugs can trigger thyroid tumors, and a recent large French study found a possible link between prolonged human use (beyond one year) and thyroid abnormalities. As a precaution, people with a personal or family history of thyroid cancer or genetic conditions like MEN2 are advised to avoid these treatments.

Potential ties to pancreatic cancer remain speculative. While GLP-1 drugs can occasionally cause pancreatitis—an inflammation that increases pancreatic cancer risk—no clear causal link has been confirmed. Curiously, early research suggests that tirzepatide, a newer dual-acting drug, may even shrink certain tumors in animal models, though its human implications remain unknown.

It’s also important to note that obesity itself is a major cancer risk factor. Whether any reduction in cancer rates seen among users of GLP-1 drugs results from the medication’s biology or simply from weight loss remains unclear.

For now, experts stress balance: GLP-1 drugs offer powerful metabolic benefits, but long-term vigilance is essential as science continues to unravel their full safety profile.

Follow for regular scientific updates

📄 RESEARCH PAPER

📌 Julien Bezin et al, "GLP-1 Receptor Agonists and the Risk of Thyroid Cancer", Diabetes Care (2025)

19/10/2025

In a groundbreaking medical advance, scientists have successfully restored hearing in people born with genetic deafness by correcting a single defective gene through viral gene therapy. The treatment uses a harmless, engineered virus to deliver a healthy copy of the gene directly into the inner ear. Once there, it reactivates dormant cells responsible for detecting sound—effectively reversing a condition once thought permanent.

Early trials have produced remarkable results: patients who had never heard a sound can now perceive speech, music, and everyday noises. The therapy targets a mutation in the *OTOF* gene, which affects thousands globally. Unlike hearing aids or cochlear implants that merely amplify sound, this approach restores natural hearing by fixing the genetic cause itself.

Researchers believe this achievement marks the start of a new era in curative medicine for hearing loss—one that could eventually replace mechanical solutions with lasting biological restoration. Beyond hearing, the same viral therapy model is being explored for treating blindness, paralysis, and heart disease.

The success of this single-gene correction highlights the immense promise of genetic medicine. It points to a future where many hereditary conditions can be repaired at their source—transforming how we think about disability and human healing.